Cosylab selected for U.S. Department of Energy’s Genesis Mission
Cosylab has been selected for the U.S. Department of Energy's (DOE) Genesis Mission to participate in a Phase I project.
News and events
June 23, 2026
White Paper on the Control Backbone for Commercial Fusion
June 11, 2026
Meet Cosylab at Quantum.Tech World 2026
June 10, 2026
Cosylab and Heron Neutron Medical Corp. Sign Letter of Intent to Advance Global Deployment of Accelerator-Based BNCT Systems
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared.
Meet Cosylab at IPAC 2026
Cosylab is exhibiting at IPAC 2026 in Deauville, 17–22 May. Whether you're in the early architecture phase, deep in construction, or heading into commissioning, book a 30-minute conversation with our accelerator controls team.
NV Centre Quantum Sensing Ready for Commercial Use
Cosylab, a provider of control systems engineering solutions for science and deep-tech industry, held a webinar "From Lab to Fab: Quantum Sensing and NV Control" that investigated the challenges of transitioning quantum sensing from laboratory prototypes to real-world systems, and how to meet them.
Do you have a question or a project?
Get in touch with our experts to see how we can help.